3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
14
Leukemia, Myelomonocytic, Chronic
7
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Biphenotypic, Acute
2
Anemia, Refractory, with Excess of Blasts
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neurofibrosarcoma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Hodgkin Disease
1
GATA2 Deficiency
1
Cytopenia
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Interventions
Dexamethasone
242
Lenalidomide
147
daratumumab
125
Bortezomib
102
pomalidomide
88
Calcium Dobesilate
76
carfilzomib
75
Cyclophosphamide
71
Specimen Handling
42
isatuximab
41
Biopsy
40
belantamab mafodotin
37
fludarabine
36
Magnetic Resonance Spectroscopy
35
talquetamab
29
Melphalan
28
dexamethasone acetate
27
dexamethasone 21-phosphate
27
auricularum
26
iberdomide
25
ixazomib
22
fludarabine phosphate
22
selinexor
21
elotuzumab
21
Whole-Body Irradiation
14
X-Rays
13
tocilizumab
12
venetoclax
11
Mycophenolic Acid
10
trametinib
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
decitabine and cedazuridine drug combination
×
1 year
×
Clear all
No trials found.